Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenue	$ 240,000	$ 461,296
Cost of revenue	125,395	313,069
Gross profit	114,605	148,227
Operating expenses:
Research and development	644,076	1,114,011
General and administrative	1,934,482	2,923,719
Sales and marketing	267,757	431,269
Total operating expenses	2,846,315	4,468,999
Loss from operations	(2,731,710)	(4,320,772)
Other income (expense)
Interest expense	(295,111)	(293,200)
Change in fair value of derivative and warrant liabilities	2,060,749	1,267,750
Amortization of derivative and warrant liabilities discount	(1,304,867)	(2,555,199)
Amortization of deferred debt issuance costs and original issue discount	(694,939)	(1,102,221)
Gain (loss) on extinguishment of debt	225,830	(2,088,074)
Other income (expense), net	(9,597)	(882)
Nonoperating Income (Expense)	(17,935)	(4,771,826)
Net loss	$ (2,749,645)	$ (9,092,598)
Basic loss per share	$ (0.02)	$ (0.08)
Diluted loss per share	$ (0.02)	$ (0.09)
Weighted average common shares outstanding	160,015,532	118,764,366